|
91 |
A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics
Enthalten in Nature Communications Bd. 14, 13.11.2023, Nr. 1, date:12.2023: 1-18
|
|
|
|
92 |
A genome-wide association scan on estrogen receptor-negative breast cancer
Enthalten in Breast cancer research Bd. 12, 09.11.2010, Nr. 6, date:12.2010: 1-17
|
|
|
|
93 |
A genome-wide association study to identify genetic markers associated with endometrial cancer grade
Enthalten in Hereditary cancer in clinical practice Bd. 10, 12.4.2012, Nr. 2, date:12.2012: 1
|
|
|
|
94 |
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
Enthalten in Breast cancer research Bd. 25, 9.8.2023, Nr. 1, date:12.2023: 1-13
|
|
|
|
95 |
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
Enthalten in Genome medicine Bd. 13, 1.2.2021, Nr. 1, date:12.2021: 1-18
|
|
|
|
96 |
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients
Enthalten in BMC cancer Bd. 15, 16.12.2015, Nr. 1, date:12.2015: 1-11
|
|
|
|
97 |
A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective
Enthalten in The Patient Bd. 13, 30.1.2020, Nr. 3, date:6.2020: 317-325
|
|
|
|
98 |
A review of methods to measure tendon dimensions
Enthalten in Journal of orthopaedic surgery and research Bd. 14, 14.1.2019, Nr. 1, date:12.2019: 1-12
|
|
|
|
99 |
A study protocol to assess the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatment
Enthalten in Pilot and feasibility studies Bd. 6, 11.5.2020, Nr. 1, date:12.2020: 1-16
|
|
|
|
100 |
ADVANCE integrated group intervention to address both substance use and intimate partner abuse perpetration by men in substance use treatment: a feasibility randomised controlled trial
Enthalten in BMC public health Bd. 21, 25.5.2021, Nr. 1, date:12.2021: 1-20
|
|
Administration
